ALPINE2: Efficacy and safety of 14-day vs 28-day inhaled aztreonam for Pa eradication in children with cystic fibrosis

Francis J Gilchrist*, Stephanie Bui, Silvia Gartner, Susanna A McColley, Harm Tiddens, Gary Ruiz, Florian Stehling, Muhsen Alani, Oksana Gurtovaya, Mark Bresnik, Timothy R Watkins, Biliana Frankovic, Marianne Skov, ALPINE2 study investigators

*Corresponding author af dette arbejde
1 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'ALPINE2: Efficacy and safety of 14-day vs 28-day inhaled aztreonam for Pa eradication in children with cystic fibrosis'. Sammen danner de et unikt fingeraftryk.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science